26 January 2016
Cardiopulmonary exercise tests in rare cardiovascular diseases
A new study published on the Journal of Rare Cardiovascular Diseases highlight the importance of CPET for this kind of pathologies.
Cardiopulmonary exercise testing (CPET) is commonly used in clinical practice for both functional and diagnostic assessments of patients with cardiovascular and pulmonary disease. It provides assessment of the integrative exercise responses involving the pulmonary, cardiovascular and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function.
The study "provide strong evidence that CPET can provide useful objective information regarding exercise tolerance and prognosis among patients after correction of congenital heart disease and pulmonary hypertension. Potential additional applications of CPET among these patients include assessment of exercise tolerance before and after therapeutic surgical and medical interventions, including exercise training programs."
The study can be downloaded for free at the following link: click here
Founded in 1980, COSMED is a privately owned company manufacturing Cardio Pulmonary and Metabolic Diagnostic Equipment. COSMED products include a full range of Spirometers, Pulmonary Function, Body Composition, Nutritional Assessment and Cardio Pulmonary Exercise systems, including Electrocardiographs, Ergometers and Assessment Software. COSMED solutions are aimed for either professional or medical use for many different applications like: Hospital, Clinics, Primary Care, University & Education in Human Physiology, Clinical Nutrition, Commercial Weight Management, Human Performance Centers, Sport Institutions and Health Club Industry. COSMED Headquarters are located in the province of Rome, Italy. COSMED has subsidiaries in the USA, China and Germany, and distributes its products internationally through a constantly growing distributor network covering more than 70 countries.